ARC launches non-touch medical thermometers at MEDICA

20 November 2013

Belfast company ARC is launching  four new highly accurate non-touch thermometers at MEDICA this week. Future research and development projects are underway to design non-touch devices that will be capable of monitoring vital signs in a medical setting (pulse, heart rate, respiratory rate, blood pressure and blood saturation).

The company is supported by Invest Northern Ireland and backed by independent investors from the US, UK, Canada, Ireland and The Netherlands. The decision to headquarter in Northern Ireland was made because of the available expertise in advanced technological research and development.

Through the recent acquisition of the Florida-based manufacturer Brooklands Inc, ARC now owns VeraTemp, a non touch thermometer sold in over 22 countries, and VeraTemp+ an advanced version which has been widely adopted within hospital and clinical settings throughout the US and UK.

ARC partners with world-class sensor manufacturers, medical device engineering experts from the University of Ulster, and clinical researchers from Queens University, Belfast. These partnerships give ARC the ability to develop unique non-touch vital signs monitoring products for the future of connected health care.

“Working with our R&D partners we have already been able to transform the non-touch thermometer technology. We are in the process of finalising a suite of products, for consumer and clinical use, that our findings show to be twice as accurate at taking body temperature readings.” explained Kevin Paul CEO of ARC.

“We want to work with distributors that already have a significant footprint in a country’s medical device market and are able to provide robust sales and marketing support; especially as our R&D plans include developing wireless non touch technology to monitor and be shared across connected health networks and clinical EMRs.”

ARC is showcasing their portfolio of new thermometers at MEDICA, taking place in Dusseldorf from the 20-23rd November 2013 in the Association of British Healthcare Industries Ltd zone, Hall 16 FO20-1/G25.


To top